Australia ADPKD (Autosomal dominant polycystic kidney disease) Market Analysis


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4105

  • Format: PPT, PDF

Australian Autosomal Dominant Polycystic Kidney Disease Therapeutics Market: Segmented by Treatment, Diagnosis and Distribution Channel – Growth, Trends, and Forecasts (2020 – 2028)

SKU: 4105 Categories: ,

The Australian Autosomal Dominant Polycystic Kidney Disease Therapeutics market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Autosomal dominant polycystic kidney disease is the most common inherited kidney disease, characterized by the growth of a number of cysts in the kidney. Patients with autosomal dominant polycystic kidney disease generally begin to show symptoms at the age of 30-40 years and rarely in childhood. The most common symptoms of autosomal dominant polycystic kidney disease include pain in the back & sides and headache. Autosomal dominant polycystic kidney disease is diagnosed by kidney imaging using ultrasound, CT scans, or MRI imaging. Genetic testing is done to confirm the diagnosis. Symptomatic treatment for autosomal dominant polycystic kidney disease involves pain medications, removal of kidney cysts, controlling high blood pressure and acidosis, restricting progression of kidney failure, etc. Along with pharmacological treatment, diet control is recommended to slow down the progression of autosomal dominant polycystic kidney disease. Recently in 2018, Therapeutic Goods Administration (TGA) approved the first and only treatment Tolvaptan to retard the progression of autosomal dominant polycystic kidney disease.

Market Growth Drivers & Restraints

The Australian market for autosomal dominant polycystic kidney disease is primarily driven by improving diagnosis rates for autosomal dominant polycystic kidney disease and the penetration of symptomatic treatment. Pharmaceutical companies and research institutes are continuously putting efforts into research and development to address the unmet needs in autosomal dominant polycystic kidney disease treatment, which is expected to accelerate the growth of the market. However, underreported epidemiology of autosomal dominant polycystic kidney disease and lack of awareness towards the disease among the population is expected to restrict the growth of the autosomal dominant polycystic kidney disease treatment market.

1. Australian Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Overview……………………..
A. Market Size
2. Market Growth Drivers & Restraints…………………………………………………….
A. Rising Cases of Genetic Mutation
B. Increase in number of people with Unhealthy Lifestyles
C. Lack of Awareness
D. High Treatment Costs
3. Major Polycystic Kidney Disease Types………………………………………….
A. Autosomal Dominant
B. Autosomal Recessive
4. Australian Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Segmentation………………
A. By Treatment
I. Pain & Inflammation Management
II. Anti-depressants
III. Kidney Stone Management
IV. Urinary Tract Infection Management
V. Kidney Failure Management
VI. Cardiovascular Risk Management
VII. Others
B. By Diagnosis
I. Molecular Genetic Testing
II. Chromosome Analysis
III. Others
C. By Distribution Channel
I. Hospital Pharmacy
II. Retail Pharmacy
III. Online Pharmacy
5. Australian Autosomal Dominant Polycystic Kidney Disease Major Products Market Share…………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Novartis Company overview, Product & Services, Strategies & Financials
B. DRL Benckiser Company overview, Product & Services, Strategies & Financials
C. Merck & Co. Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Autosomal Dominant Polycystic Kidney Disease Therapeutics Market
B. Future Opportunities
10. Conclusion

By Treatment:

On the basis of treatment, the ADPKD Therapeutics market can be bifurcated into Pain & Inflammation Management, Anti- depressants, Kidney Stone Management, Urinary Tract Infection Management, Kidney Failure Management, Cardiovascular Risk Management, and others. Pain and inflammation management treatment type segment is expected to experience highest demand, as it is the first line treatment for autosomal dominant polycystic kidney disease. Kidney failure management treatment type segment is expected to contribute considerable market share in the autosomal dominant polycystic kidney disease treatment market due to high prescription rates. Among all three distribution channels hospitals segment is expected to contribute highest revenue share in the autosomal dominant polycystic kidney disease treatment market due to high patient pool.

By Diagnosis:

On the basis of diagnosis, the ADPKD Therapeutics market can be segmented into molecular genetic testing, chromosome analysis, and others. The molecular tests that allow the quantification of messenger RNA (mRNA) and FMRP protein. Polymerase chain reaction (PCR) and Southern blot are the routine tests for the DNA diagnosis of FXS, which allow determining the number of CGG repeats and the methylation status of the FMR1 gene. Thus, the molecular genetic testing is anticipated to gain a higher market share over the forecast period.

By Distribution Channel:

On the basis of distribution channel, the ADPKD Therapeutics market has also been segmented into hospital pharmacy, retail pharmacy and online pharmacy.

Top 5 Major Players

Major players operating in the market include Novartis AG, Sandoz International GmbH, Dr. Reddy’s Laboratories, Mylan Pharmaceuticals N.V., Merck & Co. Inc.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements